COVID-19 Antigen Test Awarded Regulatory Approval in Brazil

The PerkinElmer® COVID-19 Antigen Test has been approved by the National Sanitary Surveillance Agency of Brazil (ANVISA) as a Class III in vitro diagnostic (IVD) device. This approval authorizes the sale, distribution, and use of PerkinElmer’s 15-minutes antigen test in Brazil for the qualitative detection of SARS-CoV-2, with nasal or nasopharyngeal swabs. The PerkinElmer® COVID-19 Antigen test is an accurate and efficient product to screen for the presence of COVID-19.

COVID-19 Diagnostic Lab Workflow

Examining the Workflow of a Cutting-edge COVID-19 Diagnostic Lab | In early 2020, the Netherlands identified its first COVID-19 cases. Facilitating test capacity for all symptomatic individuals resulted in extensive pressure on diagnostics labs making it challenging for non- symptomatic individuals such as travelers, teachers and professional athletes to get tested.

Go to Top